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Abstract 
Rationale: Intraoperative visualization in small surgical cavities and hard-to-access areas are 
essential requirements for modern, minimally invasive surgeries and demand significant 
miniaturization. However, current optical imagers require multiple hard-to-miniaturize components 
including lenses, filters and optical fibers. These components restrict both the form-factor and 
maneuverability of these imagers, and imagers largely remain stand-alone devices with 
centimeter-scale dimensions. 
Methods: We have engineered INSITE (Immunotargeted Nanoparticle Single-Chip Imaging 
Technology), which integrates the unique optical properties of lanthanide-based alloyed 
upconverting nanoparticles (aUCNPs) with the time-resolved imaging of a 25-micron thin 
CMOS-based (complementary metal oxide semiconductor) imager. We have synthesized core/shell 
aUCNPs of different compositions and imaged their visible emission with INSITE under either NIR-I 
and NIR-II photoexcitation.  We characterized aUCNP imaging with INSITE across both varying 
aUCNP composition and 980 nm and 1550 nm excitation wavelengths. To demonstrate clinical 
experimental validity, we also conducted an intratumoral injection into LNCaP prostate tumors in a 
male nude mouse that was subsequently excised and imaged with INSITE. 
Results: Under the low illumination fluences compatible with live animal imaging, we measure 
aUCNP radiative lifetimes of 600 µs - 1.3 ms, which provides strong signal for time-resolved INSITE 
imaging. Core/shell NaEr0.6Yb0.4F4 aUCNPs show the highest INSITE signal when illuminated at 
either 980 nm or 1550 nm, with signal from NIR-I excitation about an order of magnitude brighter 
than from NIR-II excitation. The 55 µm spatial resolution achievable with this approach is 
demonstrated through imaging of aUCNPs in PDMS (polydimethylsiloxane) micro-wells, showing 
resolution of micrometer-scale targets with single-pixel precision. INSITE imaging of intratumoral 
NaEr0.8Yb0.2F4 aUCNPs shows a signal-to-background ratio of 9, limited only by photodiode dark 
current and electronic noise. 
Conclusion: This work demonstrates INSITE imaging of aUCNPs in tumors, achieving an imaging 
platform that is thinned to just a 25 µm-thin, planar form-factor, with both NIR-I and NIR-II 
excitation.  Based on a highly paralleled array structure INSITE is scalable, enabling direct coupling 
with a wide array of surgical and robotic tools for seamless integration with tissue actuation, 
resection or ablation. 
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Introduction 
Highly sensitive imaging in hard-to-access areas 
remains a persistent challenge for optical surgical 
navigation.  This is increasingly prevalent in the 
modern era of minimally invasive cancer surgeries 
where visualizing microscopic disease over the 
entirety of a small, complex tumor bed is hindered by 
the form-factor of intraoperative optical imagers, and 
consequently microscopic residual disease (MRD) is 
common [1]. MRD significantly increases cancer 
recurrence [2, 3], necessitating substantial additional 
treatment, resulting in additional toxicity and cost.  
Despite these efforts, clinical outcomes of additional 
therapy often remain inferior to complete resection 
upfront [4]. MRD remains common despite the advent 
of new targeted molecular imaging agents [5] and 
intraoperative optical imagers [6-8].  
Intraoperative imagers have made significant 
progress for precision guided surgeries [7, 8].  
Leveraging the growing number of specific optical 
probes to label tumor cells in vivo, stand-alone 
widefield fluorescence microscopes are increasingly 
common for surgical guidance [6], and advances in 
engineering have decreased sizes to centimeter scales 
[9-16].  While intraoperative imagers have had 
significant impacts on surgical outcomes, current 
designs are limited in both miniaturization and 
adaptability.  In particular, current fluorescent probes 
that target proteins or cells necessitate the use of rigid, 
bulky optical lenses to distinguish probe emission 
from excitation light [17].  This need for rigid optical 
components has been a barrier to miniaturization. 
While advances in microfabrication have achieved 
small lenses [18-20], fundamental physical limits and 
fabrication challenges hinder further miniaturization, 
and ultra-small lenses face challenges in producing 
high resolution images.  Furthermore, the 
requirement for precise positioning of the tissue 
sample in the focal plane and imaging over a broad 
area hinder utilization of these micro-scale lenses 
intraoperatively. Optical lenses are not easily 
planarized – precluding an ultra-thin form-factor 
necessary for broad device integration.  Fiber-optic 
based imagers address this problem by guiding light 
out of the tumor bed to a large standalone imager, but 
fundamental tradeoffs between imaging area and 
flexibility hinder achieving both high maneuverability 
and rapid imaging of the entire tumor cavity.   
Chip-based imagers eliminate the need for optics 
in favor of contact imaging [21, 22] placing the imager 
in direct tissue contact to capture light before it 
diverges, microfabricated patterns to focus light [23], 
or computational approaches [24-26].  While these 
imagers are significantly more compact without the 
use of lenses, the high-performance optical filters 
required to image fluorophores with small Stokes 
shifts demands precision optical alignment [27, 28], 
substantially hindering further miniaturization for 
intraoperative imaging. 
Chip-based tissue imagers built around optical 
probes that enable time-resolved imaging [29, 30] 
would obviate the need for both filters and lenses, and 
allow for exceptionally small and flexible 
microscopes. To date this approach has been limited 
for tissue imaging by both the nanosecond radiative 
decay times of organic optical labels, and the 
similarity of decay times with tissue autofluorescence, 
masking small signals with background. Imager 
sensitivity is fundamentally limited by scattering [31] 
and cellular autofluorescence [32, 33] , which is 
strongest with UV and visible excitation and cannot 
be removed with filtering [34, 35].  Optical labels with 
longer lifetimes and photoexcitation at longer 
wavelengths in the NIR-I (700 - 1000 nm) or NIR-II 
(typically, 1000 - 1700 nm) [36] might circumvent 
these problems.  
As long-lifetime optical probes, 
lanthanide-based upconverting nanoparticles 
(UCNPs) are able to sum the energies of multiple NIR 
photons and emit at higher energies in the NIR or 
visible spectrum. UCNP luminescence efficiencies are 
up to 10 orders of magnitude higher than those of the 
best 2-photon fluorophores [37, 38] and show no 
overlap with cellular autofluorescence, no measurable 
photobleaching, even under prolonged single-particle 
excitation [39-42]. UCNPs make use of energy transfer 
upconversion between neighboring lanthanide ions, 
in which sensitizer ions sequentially transfer absorbed 
energy to luminescent emitter ions. Numerous studies 
have shown that the sensitizer/emitter pair of 
Yb3+/Er3+ doped into host matrix NaYF4 nanocrystals 
is most efficient and emits both green and red light 
with either continuous wave NIR-I (980 nm) or NIR-II 
(1550 nm) lasers. Recent work has shown that alloyed 
upconverting nanoparticles (aUCNPs), in which host 
matrix metals are replaced entirely with lanthanides, 
are significantly brighter than their doped 
counterparts, particularly at low laser fluences 
compatible with living systems [37]. A key advantage 
of UCNPs is that they can be excited with low 
fluences of either NIR-I or NIR-II light, minimizing 
interactions with both cells and semiconductors, 
while emitting at the visible wavelengths appropriate 
for most common imaging detectors.  Human 
maximum permitted exposures [43] are ~200 W/cm2 
for 5-ms pulses of either 980 nm or 1550 nm light 
(Table S1), suggesting NIR-excitable probes can be 
imaged during surgery with minimal phototoxicity. 
In this study, we have integrated both custom 
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integrated circuit imager design with nanoparticle 
engineering, and introduced INSITE, a 25 micron-thin 
microscopic imaging platform for imaging aUCNPs.  
We achieve this level of miniaturization by 
eliminating conventional fluorophores and their 
requisite optics in favor of a scalable, planar 
chip-based microscope, custom designed and 
fabricated in a 0.18-micron complementary metal 
oxide semiconductor (CMOS) process, in synergistic 
combination with long-lifetime NIR I and II-excited 
upconverting nanoparticles. To determine the optimal 
UCNPs composition to use with INSITE, we first 
investigate three different types of lanthanide-based 
aUCNPs and we subsequently present experimental 
results obtained using INSITE from an 
intratumorally-injected mouse prostate tumor 
specimen.    
Materials and Methods 
Imager design and fabrication 
An ultra-thin imager array was designed as an 
application-specific integrated circuit (ASIC) imaging 
array consisting of 2,880 pixels [44].  The resulting 
INSITE chips were custom fabricated in a 0.18 µm 
CMOS process, and thinned down to 25 µm. Each 
pixel contains a silicon photodiode (44 µm × 44 µm), 
followed by a 4-transistor front-end amplifier which 
enables a current integration over a custom-made 
MOM (metal-oxide-metal) capacitor. A subsequent 
sample-hold block controls pixel timing. 
Eliminating lenses and angle-selective gratings 
To obtain spatial resolution with minimum 
form-factor, we used on-chip angle-selective gratings 
using designs similar to those previously reported [22, 
44, 45].   Angle selective gratings are an array of 
microfabricated collimators patterned directly over 
each photodiode, effectively coupling each 
photodiode to the tissue directly opposite it, blocking 
obliquely incident background light.  
Nanocrystal synthesis 
Growth of aUCNP cores: aUCNPs were grown 
as previously described [37, 46] For, 8-nm 
NaEr0.6Yb0.4F4 cores: YbCl3 hexahydrate (64 mg, 0.16 
mmol) and ErCl3 (66 mg, 0.24 mm) were stirred in 
oleic acid (OA, 3.25 g, 10.4 mmol) and 4 mL of ODE 
and heated under vacuum for 1 h at 110 °C. The 
reaction was cooled to room temperature under N2, 
followed by the addition of sodium oleate (381 mg, 
1.25 mmol), NH4F (74 mg, 2.0 mmol) and 3 mL of 
ODE. The reaction was then held under vacuum for 
20 min, followed by 3 cycles of refilling with N2 and 
purging. The reaction temperature was then increased 
to 315 °C. After 45 min, nanocrystal growth was 
halted by removing the heating mantle and cooling 
the flask to 75 °C with a stream of air, followed by the 
addition of 20 mL of EtOH and 20 mL of acetone. The 
UCNPs were precipitated twice with EtOH and 
redispersed in 10 mL of hexane with 0.2% (v/v) OA. 
Growth of core/shell aUCNPs: Epitaxial 4-nm 
NaY0.8Gd0.2F4 shells were overgrown using adaption 
of a layer-by-layer method [46]. A 0.10 M solution of 
80:20 Y/Gd oleate (Y/Gd-OA) was prepared by 
heating YCl3 (78 mg, 0.40 mmol) and GdCl3 (26 mg, 
0.10 mmol) to 110 °C in OA (2 mL) and ODE (3 mL) 
and stirred for 15 min under vacuum. The flask was 
filled with N2 and heated to 160 °C for 30 min, 
followed by another 15 min at 110 °C under vacuum. 
In a separate flask, a 0.40 M NaTFA-OA precursor 
solution was prepared by dissolving sodium 
trifluoroacetate (163 mg, 1.20 mmol) in oleic acid (3 
mL) and applying vacuum at room temperature for 20 
min. 
Purified aUCNP cores (27 μmol) in hexane were 
added to 4 mL of OA and 6 mL of ODE. The mixture 
was held under vacuum for 30 min at 70 °C to remove 
the hexane. The shell growth was performed under N2 
at 280 °C, with alternating injections of Y/Gd-OA and 
NaTFA-OA precursor performed at 15 min intervals. 
After the last injection, the reaction was maintained at 
280 ° C for an additional 30 min to allow for complete 
shell growth, followed by rapid cooling. 
Nanoparticles were purified and stored as described 
for the aUCNP cores. 
UCNP polymer encapsulation: Hydrophobic 
core/shell aUCNPs were dispersed in hexane with 
0.2% (v/v) oleic acid to 5 μM.  For aqueous 
dispersions [37, 46], 6 mg of poly(maleic 
anhydride-alt-1-octadecene) copolymer (MW 20-25k, 
Aldrich) was dissolved to 17 μM in 0.5 mL of acetone 
and 15 mL of CHCl3. aUCNPs (0.5 nmol) in 100 μL of 
hexane were added with stirring, and the solvents 
were removed under a gentle stream of N2 overnight. 
The aUCNP/polymer residue was resuspended in a 
solution of MeO-PEG8-NH2 (ThermoFischer, 10 μmol) 
in 10 mL of 100 mM NaHCO3 buffer, pH 8.2, with 1% 
(v/v) DMSO.  This suspension was sonicated for 60 
min, heated in an 80 °C water bath for 60 min, slowly 
cooled to room temperature, and then sonicated for 30 
min.  Excess polymer was removed by spin dialysis 
(Amicon, 100 kDa MWCO), washing with 4×15 mL of 
100 mM HEPES, pH 7.4.  Retained aUCNPs were 
concentrated to 680 μL and filtered through a 0.2-μm 
filter into a sterile glass vial. 
Nanocrystal characterization 
X-ray diffraction: 1 mL of a stock solution of the 
nanoparticles in hexane was precipitated with 
addition of 2 mL of EtOH. The nanoparticle slurry 
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was spotted onto a glass coverslip or silicon wafer 
multiple times until an opaque white film formed, 
and the sample was allowed to air dry completely. 
XRD patterns were obtained on a Bruker AXS D8 
Discover GADDS X-ray diffractometer system with 
Co Kα radiation (λ= 1.78897 Å) from 2θ of 15 to 65°. 
Electron microscopy: UCNPs were precipitated, 
resuspended in hexane to 10 nM, and 7 μL was 
dropped onto ultra-thin carbon film/holey carbon 
grid, 400 mesh copper (Ted Pella). Images of the 
nanoparticles were obtained using a Zeiss Gemini 
Ultra-55 analytical scanning electron microscope. 
Dark-field images were collected in transmission 
(STEM) mode with 30 kV beam energy. HR-TEM 
images were acquired on a JEOL 2100-F 200 kV 
field-emission analytical transmission electron 
microscope. 
Dynamic Light Scattering:  Aqueous 
nanocrystal size was determined by dynamic light 
scattering measurements on a Malvern Zetasizer. 
Samples were prepared from aqueous stocks by 
dilution with ddH2O to ~50 nM. Hydrodynamic 
diameters were determined by instrument software 
based on volume fittings. 
Optical characterization:  aUCNPs emission and 
lifetimes were characterized as functions of 
illumination intensity, illumination pulse duration, 
each with either 980 or 1550 nm excitation.   Vials of 
hydrophobic aUNCPs dispersions in hexane (400 µL 
of the 0.68 µM) were placed above the imager array 
and excited with time-gated collimated lasers.  The 
beam was positioned 2 mm above the surface of the 
imager.  
INSITE samples were excited with a 980-nm 
wavelength-stabilized, single-mode, fiber-coupled 
laser diode (Qphotonics QFBGLD-980-500) followed 
by an adjustable collimator (Thorlabs ZC618FC-B) set 
to a beam diameter of 1.27 mm; or a 1550-nm 
single-mode, fiber-coupled laser diode (Qphotonics 
QFLD-1550-150S) collimated by an aspheric 
collimator (Thorlabs CFS2-1550-APC) with a beam 
diameter of approximately 0.3 mm. Both lasers were 
driven by a temperature-controlled mount driver 
(Arroyo Instruments 6310 ComboSource).  Unless 
otherwise indicated, illumination parameters and 
laser settings used for INSITE for 980 nm and 1550 nm 
are given in Table S1. 
Radiative lifetimes (𝜏𝜏) were modeled as a single 
exponential decay and were calculated by extracting 
decay profiles with a fixed moving integrating 
window (Tint). Assuming the dark current intensity 
(id) is constant over time, we derive the integrated 
pixel value IA(t) from the current density i(t): 
𝑖𝑖(𝑡𝑡) = 𝑖𝑖0𝑒𝑒(−𝑡𝑡𝜏𝜏) + 𝑖𝑖𝑑𝑑 → 𝐼𝐼𝐴𝐴(𝑡𝑡) ≡ � 𝑖𝑖(𝑢𝑢)𝑑𝑑𝑢𝑢𝑡𝑡+𝑇𝑇𝑖𝑖𝑖𝑖𝑖𝑖
𝑡𝑡
 
𝐼𝐼𝐴𝐴(𝑡𝑡) = 𝑖𝑖0𝜏𝜏 �1 − 𝑒𝑒�−𝑇𝑇𝑖𝑖𝑖𝑖𝑖𝑖𝜏𝜏 �������������
𝐼𝐼𝐴𝐴0
𝑒𝑒�−
𝑡𝑡
𝜏𝜏� + 𝑖𝑖𝑑𝑑𝑇𝑇𝑖𝑖𝑖𝑖𝑡𝑡���
𝐼𝐼𝑑𝑑
= 𝐼𝐼𝐴𝐴0𝑒𝑒�−𝑡𝑡𝜏𝜏� + 𝐼𝐼𝑑𝑑 
where τ and ID are the emission decay lifetime 
and dark current level in the pixel, respectively [47]. 
Dark current level was subtracted from waveforms. 
Effects of excitation (Texc) pulse duration on 
emission signal intensity: To extract the excitation 
duration dependency, the aUCNPs were excited for 
increasing durations of time (Texc) and the emission 
intensity was measured.  This duration represents 
how long the nanoparticles are illuminated with the 
excitation light source before the start of the 
time-resolved imaging sequence.  
Fabrication of PDMS micro-wells 
We fabricated 500-micron cubic wells for 
aUCNP coating purposes by micro- 
patterning wells into a PDMS substrate. We 
subsequently coated the internal surface of 
the PDMS micro-well with 10 µL of 0.68 µM 16-nm 
NaEr0.6Yb0.4F4 core/shell aUCNPs in hexane, giving a 
final surface concentration of 5 pM/mm2 of adsorbed 
UCNP. This aUCNP-coated structure was imaged 
with INSITE using a 1550 nm laser at 60 W/cm2. 
Imaging aUCNPs in tissue with INSITE  
Animal experiments were conducted according 
to protocols approved by the UCSF Animal Care and 
Use Committee. Tumor-bearing mice were generated 
by subcutaneous implantation of prostate cancer 
(LNCaP) cells bilaterally over the flank of a nude male 
mouse (5-week-old, Tarconic Farms).  Tumors were 
allowed to grow to 1 cm in diameter.  Mice were 
anesthetized and single tumors were injected with 
injected with 25 µL of 250 nM polymer-encapsulated 
26-nm (16-nm cores with 5-nm shells) NaEr0.8Yb0.2F4 
core/shell aUCNP dispersions on the left side tumor 
of the mouse (ventral left), and the right side tumor 
was used as a reference and negative control. Mice 
were imaged with an IVIS Spectrum (In Vivo Imaging 
System, PerkinElmer) equipped with a 980-nm 
continuous wave laser (Qphotonics) and 780-nm short 
pass filter (Chroma), to reject 980-nm interference on 
the IVIS camera. Emission was collected from 650-670 
nm in the 4F9/2 Er3+ band using 2.5-s integration times. 
Tumors with aUCNPs were excised and imaged 
by INSITE with a 1550-nm pulsed laser (Qphotonics) 
scanned across the sample in 300-μm increments.   
Excised tumors were also imaged under a widefield 
microscope (Leica DMIRB) customized to image 
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aUCNPs using a 980 nm laser (Qphotonics) at 1 
W/cm2. 
Results and Discussion 
Optimization of UNCPs for INSITE Imaging 
To determine the optimal composition of 
aUCNPs for use with INSITE (Figure 1B), we 
synthesized a series of core/shell aUCNPs with 
varying Yb3+ and Er3+ content to measure emission 
using either 980 nm or 1550 nm photoexcitation. 
aUCNP cores (8 nm) were synthesized with 20/80, 
40/60, or 80/20 Yb3+/Er3+ ratios and overgrown with 
inert 4-nm shells [37]. These hydrophobic 
nanocrystals were characterized by transmission 
electron microscopy (TEM) to measure size, 
dispersity, and crystallinity (Figures S1-2). With these 
nanocrystals in the experimental setup (Figure 2), we 
measured the initial emission intensity, 𝐴𝐴0 , 
luminescence lifetime, 𝜏𝜏 , (Figure 3) and total 
integrated emission count, 𝐴𝐴0𝜏𝜏 , at a given power 
density (8 W/cm2 at either 980 and 1550 nm) (Figure 
4). Measured decays for varying aUCNP 
compositions range from 600 µs to 1.3 ms at either 980 
nm or 1550 nm excitation.  These values are longer 
than measured [37] or calculated, but consistent with 
UCNP power-dependence given the lower excitation 
powers used here. 
While most Yb3+/Er3+ upconversion is nominally 
a 2-photon process with following 980-nm excitation 
of the Yb3+ 2F5/2 manifold, 1550 nm excitation of the 
Er3+ 4I13/2 manifold leads to upconversion via a 
nominal 3-photon process (Figure 1a).  For all aUCNP 
compositions, NIR-I excitation produces a stronger 
signal than with NIR-II, consistent with significantly 
higher efficiency of 2-photon versus 3-photon 
upconversion processes [48].  At both excitation 
wavelengths, NaEr0.6Yb0.4F4 aUCNPs are the brightest 
composition (Figure 4) as measured by INSITE, 
although single nanoparticle studies at low 980-nm 
fluences have shown little difference in absolute 
brightness between aUCNP compositions [37]. 
Differences in brightness here may be due to subtle 
variations in radiative lifetime, since the INSITE 
100-µs time gating (Tdelay) will cause greater losses in 
aUCNPs with faster upconversion.  Kinetic modeling 
has shown that Yb3+/Er3+ lifetimes are complex and 
deeply power-dependent [42, 48] but alloyed 
compositions do show kinetic differences in both 
green (4S3/2, 2H11/2) and red (4F9/2) Er3+ emission [48]. 
 
 
Figure 1. INSITE imaging of upconverting nanoparticles. (A) Multiphoton energy absorption, transfer, and emission in Yb3+/Er3+-based aUCNPs following 
either NIR-I (980 nm) or NIR-II (1550 nm) excitation.  (B) Cartoon of INSITE directly integrated onto surfaces, such surgical glove. (C) Diagram of the time-resolved 
image acquisition scheme. Texc, pulse excitation time; Tint, emission signal integration time; Tdelay, time gating delay. (D) Angle-selective gratings used to achieve lensless 
image acquisition and block obliquely incident background light. 
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Figure 2. INSITE configuration for imaging of aUCNP dispersions. Laser beam width is 300 µm. 
 
Figure 3. Emission decays of aUCNPs (Tint = 1 ms, Texc = 5 ms) as measured by pixel output at (A) 8 W/cm2 of 980 nm excitation, or  (B) 60 W/cm2 of 1550 nm 
excitation. Tint is integation time; Texc is duration of exciation light pulse. 
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Figure 4. Integrated visible emission as a function of aUCNP composition at either 980 and 1550 nm excitation, both with 8 W/cm2 excitation power density.  
Hexane blank is without aUCNPs. 
 
Long decay lifetimes enable time-resolved 
imaging in modern CMOS technologies, and alleviate 
the need for optical filters entirely. While time 
resolved imaging has been demonstrated with 
organic and protein fluorophores, their nanosecond 
radiative lifetimes [17] make large, dense array based 
imaging impossible, as arrayed CMOS sensors cannot 
readily detect on timescales shorter than tens of 
microseconds [49, 50]. Although single photon 
avalanche diodes that require specialized fabrication 
processes have been demonstrated to operate at these 
timescales [51], we require a massively parallel 
array-based approach for larger spatial coverage, high 
fill factor, and adequate spatial resolution necessary 
for efficient chip-based imaging.  Consequently, a 
chip-based imager using time resolved imaging 
requires optical probes with microsecond lifetimes, 
such as upconverting nanoparticles [37, 47, 48]. The 
design of UCNPs with a core-shell prevents rapid 
quenching, as tested here, significantly elongating the 
decay lifetime.  The 0.6-1.3 ms decay lifetimes open 
the door to time-resolved imaging in an array-based 
CMOS imager.   
The chip-based time-resolved imaging method 
takes advantage of these uniquely long emission 
lifetimes the aUCNPs studied here, and alleviates the 
need for high performance frequency-selective (color) 
filters by separating the emission and excitation 
signals in the time domain rather than in frequency 
domain, a strategy that can be implemented in 
modern high-speed integrated circuit design.  In a 
chip-based imager, we implement this by briefly 
pulsing the excitation light (Texc = 5 ms duration) 
while the imaging pixels are not integrating. After the 
excitation light is turned off, the pixels are turned on, 
and integrate the emission signal from the aUCNPs 
for 1 ms (Figure 1C).  Since there is no background 
excitation light at this time, the need for an optical 
filter is eliminated.  The illumination and signal 
acquisition scheme (Figure 1C), where the excitation 
light source is pulsed for Texc, and subsequently 
turned off, after which the emission signal from the 
aUCNPs is acquired and integrated by the imager. 
Any interference and unwanted signal caused by the 
excitation light can be rejected by delaying (Tdelay) the 
integration window start point. 
aUCNP brightness as a function of NIR-I and 
NIR-II excitation intensity and pulse duration  
In order to minimize overall imaging time for 
rapid imaging which consists of illumination, 
integration and chip readout, and duration of optical 
exposure for tissue, we investigated the optimal time 
for the illumination pulse.  We find increases in 
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emission intensity for all three aUCNP compositions 
with increasing Texc up to a threshold of 5 ms, after 
which emission intensity plateaus, and longer 
integration pulses cause a measurable increases in 
detector noise (Figure S3).  Pulsed illumination is safer 
than continuous wave (CW) illumination, and human 
maximum permitted exposures are ~3 orders of 
magnitude higher for pulsed versus CW at both NIR-I 
and NIR-II wavelengths [43].  These 5-ms pulses then 
permit significantly higher excitation fluences, with 
resulting increased sensitivity and signal-to- 
background ratios. 
To quantify the relationship between excitation 
light intensity and emission intensity, all 3 aUCNP 
compositions were excited at increasing illumination 
intensities at both 980 nm and 1550 nm, and emission 
intensity was measured by INSITE (Figure S4).  UCNP 
excitation is nominally a 2- and 3-photon process, but 
the relationship between illumination power density 
and emission intensity is complex and varies with 
both excitation and detection schemes [48].  While 
varying illumination intensity over orders of 
magnitude below saturation elicits non-linear 
responses [37, 39], the linear response we observed 
here may be due to the small range of illumination 
intensities, time-gating, and pulse sequence.    
Optical probes excited in the NIR-I and NIR-II 
spectrum are ideal for both in vivo imaging and 
CMOS-based tissue imaging chips. NIR-I and NIR-II 
illumination enables deeper tissue penetration and 
lower scatter than illumination in the visible 
spectrum, common to most optical labels. 
Furthermore, aUCNP excitation in the NIR-I and 
NIR-II regions is particularly attractive for 
CMOS-based imagers, as it minimally interacts with 
silicon.  At these wavelengths, the thin imager itself is 
effectively transparent and minimal background and 
noise is generated in the imager by the illumination 
light.  
Despite the stronger aUCNP emission signal 
with NIR-I excitation, NIR-II light is more weakly 
absorbed by silicon and may be advantageous for 
chip-based microscopes.  The silicon bandgap energy 
corresponds to ~1100 nm [52] and at wavelengths 
above that, photons pass through with relatively little 
interaction. At shorter wavelengths, particularly in 
the visible, photon interaction with the chip can 
introduce substantial background signal.  Excitation 
with 980 nm light (just below the silicon bandgap) 
produces a small background signal with INSITE 
(Figure 4 and Figure S4, hexane), while for 1550 nm 
illumination (substantially above the silicon 
bandgap), such background is absent. Because 
background substantially affects signal to noise ratios, 
using higher excitation powers at 1550 nm to 
compensate for lower aUCNP emissions may 
ultimately lead to better image quality. 
Upconversion, along with NIR illumination and 
long decay times, enables high contrast and 
sensitivity imaging by eliminating autofluorescence 
background.    Upconversion places the emission 
photos in the high responsivity (sensitivity) range of 
silicon-based detectors, enabling imaging of these 
nanoparticles [37].  In comparison, light from a 
conventional fluorophore excited in the NIR I or NIR 
II spectrum, will emit a lower energy (longer 
wavelength) photon, which would pass through 
silicon undetected.   
INSITE imager design 
In order to determine whether an ASIC can 
image optical labels without the use of conventional 
focusing lenses and optical filters, we designed and 
fabricated an imaging array capable of time resolved 
imaging (Figure 1).  Absent optics, the imaging chip 
can be easily thinned to just 25 microns and placed 
directly on tissue, increasing sensitivity through 
proximity – capturing light from optical labels before 
it diverges. The key to this platform is the 
transformation of molecular imaging from the color 
(frequency) domain to the time domain enabled by 
aUCNPs [37]. We accomplish this using synergistic 
design of modern integrated-circuits and 
upconverting nanoparticles.  A key advantage of 
using CMOS-based imaging platform is the ability to 
integrate in-pixel electronics enabling signal 
processing directly on-chip, eliminating the need for 
optical lenses.  This imager addresses both 
elimination of lenses and filters simultaneously, 
making it possible to obtain optical images with a 
much smaller form-factor.   
INSITE spatial resolution 
To determine the imaging quality achievable 
with a 25-micron thin microscope, we used a 1550 nm 
excitation source to excite the aUCNP-coated 
microstructure and acquired the image using 
time-resolved imaging. The custom-fabricated PDMS 
micro-well and the CMOS imager demonstrate that 
INSITE is able to resolve the spatial features of the 
micro-well (Figure 5A and 5B) with nearly 
single-pixel sharpness (55 µm), translating into a 
spatial resolution performance sufficient for detecting 
microscopic residual disease. A cross-section of the 
acquired signals (Figure 5C), shows three different 
regions of the image. Aside from the micro-well and 
the background, the intermediate zone represents the 
PDMS surrounding the micro-well.  Due to the 
porosity of the PDMS, small amounts of aUCNPs 
diffuse into the surrounding area, generating a small 
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signal in this area.  For a concentration of 1012 
aUCNPs per mm2, the measured average 
signal-to-background ratio is 6.5. The background is 
dominated by the dark pixel current, which can 
ultimately be subtracted out.   
INSITE achieves this spatial resolution without 
the use of conventional lenses through both proximity 
to the tissue sample and direct integration of on-chip 
microfabricated collimators, and is limited only by the 
pixel size. INSITE uses angle-selective gratings (ASG) 
to improve spatial resolution with chip-based 
imaging [22, 45]. ASG are arrays of microcollimators 
fabricated directly on each pixel using only the 
inherent metal interconnect layers common to all 
CMOS process – obviating the need for any 
postprocessing and not adding any thickness to the 
imager itself.  The  versatility of CMOS fabrication 
technology has led to the on-chip integration of a 
variety of optical components such as 
wavelength-selective optical filters [21, 53] that could 
be tuned to be compatible with quantum dot 
applications [54], or stacked diffraction gratings for 
lensless 3D imaging [55] to reject angled incoming 
light and decrease blur in the image. Other lensless 
imaging platforms have also been reported in [24, 26, 
56] that leverage computational techniques.  As 
demonstrated here, the elimination of optical filters 
and focusing optics enables placement of the custom 
designed INSITE imaging chip directly against the 
sample itself, capturing light before it diverges, 
achieving both spatial resolution and increased 
sensitivity without optics.   
INSITE tumor imaging 
To determine the applicability of INSITE to 
tissue imaging, we injected a prostate tumor with 
aqueous 250 nM polymer-encapsulated 26-nm 
NaEr0.8Yb0.2F4 aUNCPs.  Hydrophobic, as-synthesized 
nanocrystals were transferred to water by 
encapsulation within amphiphilic polymers 
terminated with short PEG chains [57, 58].  Previous 
work with these and similar amphiphilic polymers 
[39, 46] has shown that nanoparticle brightness is fully 
preserved by retention of the oleic acid surfactant 
layer.  Polymer encapsulation increases nanoparticle 
diameters by 3-5 nm (Figure S2 and [59]) and present 
multiple surface carboxylates that, along with the 
PEG chains, may minimize non-specific endocytosis 
[57, 58]. aUCNP-injected mice were imaged a 
custom-modified IVIS imager using NIR-I 
illumination, showing colocalization of the tumor and 
aUCNPs (Figure 6A). Images of a tumor on the 
contralateral side of the mouse without aUCNP 
injection shows no measurable visible emission 
(background dark current only). To ensure aUCNPs 
were being imaged, the spectrum of the acquired 
 
Figure 5. (A) Photograph of CMOS contact imager and PDMS micro-well holding aUCNPs, fabricated for this study.   (B) Time-resolved image of the 
aUCNP-coated surface of the micro-well.  Normalized emission intensity shown as in grayscale legend. Section (I) is background, (II) is outer PDMS with aUNCPs 
diffused into PDMS, and (III) is microwell with aUCNP sample.   (C) Cross-section emission profile for the three regions in (B). 
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emission signal was measured (Figure 6B), displaying 
the characteristic emission spectrum of the 
nanoparticles, with the two major visible emission 
bands of the aUCNPs at 545 nm and 655 nm. Using 
the aUCNP emission band at 650-670 nm, the 
signal-to-background ratio is 15.  
 To determine if the aUCNPs injected into the 
tumor can be visualized with INSITE alone, we next 
excised the injected tumor and imaged with the 
INSITE chip imager.  Figure 7 shows the photograph 
of the excised tumor sample on the 25-micron imaging 
chip.  For reference, we image the excised tumor on a 
microscope (Figure 8A), and the image acquired with 
INSITE reveals a distinct area of aUCNPs in the 
excised tissue (Figure 8B) with a signal to background 
ratio of 9, closely matching the performance of the 
IVIS imager, which incorporates high performance 
optical filters and a cooled CCD camera. Results from 
these experiments demonstrate that the ultra-thin 
time-resolved CMOS imager, custom designed to 
image engineered aUCNPs, is capable of imaging 
within tissue, with no background autofluorescence 
and with little to no additional interference from the 
excitation light.  More extensive work in toxicology 
and biodistribution with immunotargeted aUCNPs 
will be needed to assess the suitability for these 
nanoparticles for tumor targeting in mice or human 
tissue. 
 
 
Figure 6. Live mouse images of intratumorally-injected NaEr0.8Yb0.2F4 aUCNPs with 8 W/cm2 980 nm excitation. (A) Images of aUCNPs-injected into mouse 
prostate tumor (left) and non-injected side (right). Emission intensity as in colored legend. (B) Measured emission spectrum of the injected and non-injected sides, 
showing tumor-specific Er3+ emission bands at 545 and 655 nm. 
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Figure 7.  Photograph of the tumor injected with aUCNPs (left side of mouse, from Figure 6) is excised and placed directly on INSITE for imaging.  The area within 
the excised tissue where the aUCNPs are located (aUCNP spot) is circled.  The remainder of the tissue does not contain aUCNPs. The path of the illumination laser 
is drawn in red. *This is for illustrative purposes only, and is not an image of the actual laser beam, which is not visible. 
 
Figure 8. (A) Microscope image of excised tumor injected with 25 µL of a 250 nM aqueous dispersion of aUCNPs, excited with 1 W/cm2  980 nm, showing distinct 
localization of aUCNPs.  (B) Images of NIR-II laser scanning of tumor, from top to bottom in increments of 300 µm (numbered 1-8). At each position, an image of the 
tumor sample is acquired with INSITE using a 5 millisecond-pulsed 60 W/cm2 1550-nm laser for illumination. 
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We have designed a 25-micron thin microscope, 
INSITE, and optimized it for imaging aUCNPs with 
NIR-I or NIR-II excitation. UCNPs have been 
successfully used for in vivo animal imaging [60-64], 
but to date the imagers remain too bulky and 
illumination power requirements are too high to be 
used in minimally invasive surgeries.  Using 
complementary design of imager and optical label, 
INSITE synergistically integrates the advantages of 
both modern integrated circuit design with 
nanoparticle engineering.  Leveraging the engineered 
long luminescent lifetimes and upconversion of 
aUCNPs we demonstrate the optimal aUCNP 
composition for chip-based time-resolved imaging. 
We custom design our chip-based imager around the 
excitation and emission wavelengths of aUCNPs and 
their decay time constants. This eliminates optical 
filters and the requisite focusing optics without 
sacrificing background rejection.  Pulsed illumination 
allows a 200x-1000x increase in instantaneous optical 
illumination power, while still respecting ANSI safety 
limits.  Absent optics, the INSITE platform is thinned 
to just 25 microns at which point it becomes flexible, 
allowing integration on virtually any planar or curved 
surgical instrument without disruption of form-factor. 
On-chip integration of both optical sensing and signal 
processing enables conversion of an optical signal to 
an electronic one (and amplification) at the point of 
imaging – enabling only thin flexible wires to transmit 
power and data from the chip, achieving a level of 
flexibly and maneuverability not achievable with 
current approaches.  The scalable design, inherent to 
array-based integrated circuits allows further 
customization to any device or tumor bed size, while 
the parallel operation of the imaging array ensures 
imaging time remains constant, regardless of size.  
This maintains the rapid imaging needed for seamless 
intraoperative evaluation of large surface areas. 
Future form-factors for in vivo imaging may fully 
integrate illumination with optical detection, such as 
by surrounding the imaging chip with laser diodes, or 
leveraging the transparency of silicon above 1100 nm 
to illuminate tissue via laser diodes affixed to the chip 
back-side.  Conjugation of aUCNPs to molecules 
targeted to tumor cells can further enhance tumor 
specificity of these imagers, and INSITE has the 
potential to significantly reduce the rate of positive 
margins in cancer surgeries, significantly impacting 
patient outcomes across the cancer spectrum.  
Conclusion 
This work provides a new strategy to bring 
NIR-I and NIR-II excitation-based imaging, with high 
sensitivity, into intraoperative imaging by 
introducing a time-resolved contact CMOS imaging 
array that no longer requires optics to resolve the 
image and can easily achieve a surgically-compatible 
form-factor. The integration of probe design, in terms 
of long-lifetime aUCNPs, with microscope 
engineering represents an initial foray into co-design 
of nanoparticles and imagers, and can be further 
optimized through iterative rounds of optimization 
for each element. The scalability inherent to CMOS 
technology will allow fabrication of larger arrayed 
image sensor to achieve greater spatial coverage, 
while preserving spatial resolution and imaging 
speed, than current imaging platforms. 
Abbreviation 
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